3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is growing attracting clinical focus due to initial data suggesting distinct pharmacological actions. Preliminary analyses demonstrate that https://www.pinterest.com/pin/1140888518124046392/